Shares of Biotech MicroCap Rip on Licensing Talks
13 Junho 2024 - 12:40PM
AllPennyStocks.com
This firm develops therapeutic products using cell and tissue
protocols, primarily involving adult stem cells. And news of a
potential licensing agreement is sending shares soaring in
morning...
To read the full story on AllPennyStocks.com, click
here.
BioRestorative Therapies (NASDAQ:BRTX)
Gráfico Histórico do Ativo
De Fev 2025 até Mar 2025
BioRestorative Therapies (NASDAQ:BRTX)
Gráfico Histórico do Ativo
De Mar 2024 até Mar 2025